See more : Aurona Industries, Inc. (8074.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Waters Corporation (WAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Waters Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Soligen Technologies, Inc. (SGTN) Income Statement Analysis – Financial Results
- Tekken Corporation (1815.T) Income Statement Analysis – Financial Results
- Tejon Ranch Co. (TRC) Income Statement Analysis – Financial Results
- Lancaster Resources Inc. (LCR.CN) Income Statement Analysis – Financial Results
- JX Luxventure Limited (LLL) Income Statement Analysis – Financial Results
Waters Corporation (WAT)
About Waters Corporation
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.96B | 2.97B | 2.79B | 2.37B | 2.41B | 2.42B | 2.31B | 2.17B | 2.04B | 1.99B | 1.90B | 1.84B | 1.85B | 1.64B | 1.50B | 1.58B | 1.47B | 1.28B | 1.16B | 1.10B | 958.21M | 889.97M | 859.21M | 795.07M | 704.40M | 618.80M | 465.50M | 391.10M | 333.00M |
| Cost of Revenue | 1.20B | 1.25B | 1.16B | 1.01B | 1.01B | 992.56M | 947.07M | 891.45M | 842.67M | 824.91M | 783.46M | 737.61M | 730.49M | 653.30M | 594.88M | 661.27M | 631.12M | 536.19M | 478.36M | 454.81M | 397.85M | 373.47M | 311.23M | 265.90M | 235.60M | 213.40M | 158.70M | 133.60M | 109.70M |
| Gross Profit | 1.76B | 1.72B | 1.63B | 1.36B | 1.40B | 1.43B | 1.36B | 1.28B | 1.20B | 1.16B | 1.12B | 1.11B | 1.12B | 990.07M | 903.82M | 913.86M | 841.93M | 744.04M | 679.88M | 649.73M | 560.36M | 516.50M | 547.98M | 529.17M | 468.80M | 405.40M | 306.80M | 257.50M | 223.30M |
| Gross Profit Ratio | 59.57% | 58.00% | 58.49% | 57.44% | 58.00% | 58.98% | 58.99% | 58.87% | 58.74% | 58.53% | 58.86% | 59.99% | 60.54% | 60.25% | 60.31% | 58.02% | 57.16% | 58.12% | 58.70% | 58.82% | 58.48% | 58.04% | 63.78% | 66.56% | 66.55% | 65.51% | 65.91% | 65.84% | 67.06% |
| Research & Development | 174.95M | 176.19M | 168.36M | 140.78M | 142.96M | 143.40M | 132.59M | 125.19M | 118.55M | 107.73M | 100.54M | 96.00M | 92.35M | 84.27M | 77.15M | 81.59M | 80.65M | 77.31M | 66.91M | 65.24M | 59.24M | 51.92M | 46.60M | 42.51M | 36.10M | 34.40M | 80.80M | 20.90M | 17.70M |
| General & Administrative | 690.34M | 651.03M | 619.97M | 547.70M | 528.79M | 529.90M | 538.70M | 502.03M | 484.75M | 500.71M | 481.97M | 464.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 7.00M | 7.00M | 7.00M | 6.00M | 6.00M | 7.00M | 6.00M | 11.00M | 11.00M | 12.00M | 11.00M | 13.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 736.01M | 658.03M | 626.97M | 553.70M | 534.79M | 536.90M | 544.70M | 513.03M | 495.75M | 512.71M | 492.97M | 477.27M | 490.01M | 445.46M | 421.40M | 426.70M | 403.70M | 357.66M | 321.69M | 300.15M | 264.25M | 246.82M | 269.71M | 246.39M | 226.60M | 206.20M | 167.30M | 148.50M | 132.70M |
| Other Expenses | 32.56M | 6.37M | 7.14M | 10.59M | 9.69M | -47.79M | 6.74M | 9.89M | 10.12M | 10.63M | -1.58M | 13.83M | 9.73M | 10.41M | 10.66M | 15.82M | 8.70M | 5.44M | 8.13M | -466.00K | 16.77M | 13.95M | 82.14M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
| Operating Expenses | 943.52M | 840.58M | 802.47M | 705.06M | 687.44M | 688.02M | 684.04M | 648.11M | 624.42M | 631.07M | 603.42M | 587.10M | 592.09M | 540.14M | 509.22M | 524.10M | 493.05M | 440.41M | 396.73M | 364.93M | 340.27M | 312.68M | 398.45M | 318.34M | 292.30M | 269.00M | 269.20M | 187.20M | 166.90M |
| Cost & Expenses | 2.14B | 2.09B | 1.96B | 1.71B | 1.70B | 1.68B | 1.63B | 1.54B | 1.47B | 1.46B | 1.39B | 1.32B | 1.32B | 1.19B | 1.10B | 1.19B | 1.12B | 976.59M | 875.08M | 819.73M | 738.12M | 686.15M | 709.68M | 584.24M | 527.90M | 482.40M | 427.90M | 320.80M | 276.60M |
| Interest Income | 16.62M | 11.02M | 12.22M | 16.27M | 22.06M | 38.81M | 36.08M | 20.69M | 10.71M | 7.02M | 4.39M | 4.21M | 2.62M | 1.86M | 3.04M | 0.00 | 0.00 | 0.00 | 19.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 98.86M | 37.78M | 32.72M | 32.80M | 26.63M | 9.83M | 20.76M | 24.23M | 25.53M | 27.17M | 25.66M | 23.87M | 19.35M | 12.07M | 7.95M | 17.56M | 25.69M | 32.19M | 8.59M | 0.00 | 0.00 | 5.51M | 2.10M | 10.64M | 9.00M | 34.90M | 30.10M | 39.20M | 39.20M |
| Depreciation & Amortization | 165.91M | 130.42M | 131.68M | 125.36M | 105.30M | 108.41M | 106.00M | 96.45M | 10.12M | 10.63M | 9.92M | 13.83M | 9.73M | 10.41M | 10.66M | 65.27M | 53.32M | 46.16M | 43.69M | 41.93M | 33.85M | 37.19M | 33.95M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
| EBITDA | 1.00B | 1.01B | 958.43M | 777.97M | 822.09M | 799.64M | 783.97M | 725.01M | 668.23M | 638.31M | 597.04M | 584.53M | 597.61M | 514.35M | 454.91M | 475.98M | 402.20M | 360.78M | 326.84M | 337.67M | 253.94M | 241.01M | 183.48M | 240.26M | 206.10M | 164.80M | 58.70M | 88.10M | 72.90M |
| EBITDA Ratio | 33.86% | 34.18% | 35.03% | 33.28% | 33.66% | 33.06% | 33.95% | 29.42% | 28.66% | 27.35% | 27.61% | 28.90% | 29.08% | 28.01% | 27.04% | 29.30% | 27.30% | 28.44% | 28.76% | 29.19% | 27.93% | 29.75% | 30.91% | 30.22% | 29.26% | 29.30% | 16.15% | 28.79% | 24.53% |
| Operating Income | 817.68M | 873.40M | 821.71M | 645.49M | 708.46M | 739.77M | 661.86M | 624.34M | 567.45M | 517.91M | 517.34M | 511.49M | 528.60M | 449.93M | 394.60M | 389.75M | 348.88M | 295.15M | 283.16M | 284.86M | 219.17M | 196.41M | 149.53M | 210.83M | 176.50M | 136.40M | 37.60M | 70.30M | 56.40M |
| Operating Income Ratio | 27.66% | 29.39% | 29.50% | 27.29% | 29.44% | 30.57% | 28.66% | 28.81% | 27.78% | 26.03% | 27.17% | 27.74% | 28.55% | 27.38% | 26.33% | 24.74% | 23.68% | 23.05% | 24.45% | 25.79% | 22.87% | 22.07% | 17.40% | 26.52% | 25.06% | 22.04% | 8.08% | 17.97% | 16.94% |
| Total Other Income/Expenses | -81.43M | -35.55M | -15.51M | -34.58M | -30.22M | -57.63M | -21.10M | -24.93M | -25.53M | -27.17M | -27.24M | -23.87M | -19.35M | -12.07M | -7.95M | -17.56M | -25.69M | -36.78M | -8.59M | 813.00K | 4.51M | -1.00M | -2.10M | 135.00K | -9.00M | -34.90M | -30.10M | -39.20M | -39.20M |
| Income Before Tax | 736.24M | 837.85M | 806.19M | 610.91M | 678.24M | 682.15M | 641.10M | 600.11M | 541.92M | 490.74M | 490.11M | 487.63M | 509.25M | 437.86M | 386.65M | 372.19M | 323.19M | 262.96M | 274.56M | 285.67M | 223.69M | 195.41M | 147.43M | 210.96M | 167.50M | 101.50M | 7.50M | 31.10M | 17.20M |
| Income Before Tax Ratio | 24.90% | 28.19% | 28.94% | 25.83% | 28.18% | 28.19% | 27.76% | 27.69% | 26.53% | 24.67% | 25.74% | 26.45% | 27.51% | 26.64% | 25.80% | 23.63% | 21.94% | 20.54% | 23.71% | 25.86% | 23.34% | 21.96% | 17.16% | 26.53% | 23.78% | 16.40% | 1.61% | 7.95% | 5.17% |
| Income Tax Expense | 94.01M | 130.09M | 113.35M | 89.34M | 86.04M | 88.35M | 620.79M | 78.61M | 72.87M | 59.12M | 40.10M | 26.18M | 76.28M | 56.10M | 63.34M | 49.71M | 55.12M | 40.76M | 72.59M | 61.62M | 52.80M | 43.19M | 32.88M | 54.85M | 45.20M | 27.10M | 15.80M | 11.20M | 3.10M |
| Net Income | 642.23M | 707.76M | 692.84M | 521.57M | 592.20M | 593.79M | 20.31M | 521.50M | 469.05M | 431.62M | 450.00M | 461.44M | 432.97M | 381.76M | 323.31M | 322.48M | 268.07M | 222.20M | 201.98M | 224.05M | 170.89M | 147.71M | 114.54M | 145.34M | 122.30M | 74.40M | -8.30M | -2.40M | 2.00M |
| Net Income Ratio | 21.72% | 23.81% | 24.87% | 22.05% | 24.61% | 24.54% | 0.88% | 24.06% | 22.97% | 21.70% | 23.63% | 25.03% | 23.39% | 23.23% | 21.57% | 20.47% | 18.20% | 17.36% | 17.44% | 20.28% | 17.83% | 16.60% | 13.33% | 18.28% | 17.36% | 12.02% | -1.78% | -0.61% | 0.60% |
| EPS | 10.87 | 11.80 | 11.25 | 8.40 | 8.76 | 7.71 | 0.25 | 6.46 | 5.70 | 5.12 | 5.27 | 5.25 | 4.77 | 4.13 | 3.37 | 3.25 | 2.67 | 2.16 | 1.77 | 1.87 | 1.39 | 1.13 | 0.88 | 1.14 | 0.99 | 0.61 | -0.07 | -0.02 | 0.01 |
| EPS Diluted | 10.84 | 11.73 | 11.17 | 8.36 | 8.69 | 7.65 | 0.25 | 6.41 | 5.65 | 5.07 | 5.20 | 5.19 | 4.69 | 4.06 | 3.34 | 3.21 | 2.62 | 2.13 | 1.74 | 1.82 | 1.34 | 1.09 | 0.83 | 1.06 | 0.92 | 0.57 | -0.07 | -0.02 | 0.01 |
| Weighted Avg Shares Out | 59.08M | 59.99M | 61.58M | 62.09M | 67.63M | 76.99M | 79.79M | 80.79M | 82.34M | 84.36M | 85.43M | 87.84M | 90.83M | 92.39M | 95.80M | 99.20M | 100.50M | 102.69M | 114.02M | 119.64M | 123.19M | 130.49M | 130.56M | 127.57M | 123.01M | 119.72M | 116.51M | 120.00M | 110.00M |
| Weighted Avg Shares Out (Dil) | 59.27M | 60.33M | 62.03M | 62.41M | 68.17M | 77.62M | 80.60M | 81.42M | 83.09M | 85.15M | 86.55M | 88.98M | 92.33M | 94.06M | 96.86M | 100.56M | 102.51M | 104.24M | 115.95M | 123.07M | 127.58M | 135.76M | 137.51M | 136.74M | 132.63M | 119.72M | 116.51M | 120.00M | 110.00M |
Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory
Waters (WAT) unveils Rheo-IS accessory for its TA Instruments Discovery Hybrid Rheometers, bolstering its overall portfolio.
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges
News Summary: Waters Oasis™ Dual-phase PFAS Analysis Cartridges simplify sample preparation for EPA 1633 testing for analysis of PFAS concentrations in non-potable water, soils, biosolids, and tissue. Reduces sample preparation time by 20% and sample processing time by approximately 30...
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
News Summary: New Rheo-Impedance Spectroscopy (Rheo-IS) accessory enables battery scientists to better assess electrode slurry composition quality under real-world and process-relevant conditions. The Rheo-IS accessory for TA Instruments Discovery™ Hybrid Rheometers employs a unique, patent-pending design that is friction-free, allowing...
Bearish Engulfing Pattern Marks Top For Nvidia? Candle Patterns Suggest Dangerous Waters For Leading Growth Stocks
Large cap growth stocks have been outperforming for quite some time, with semiconductors perhaps the most representative of the strength of that trade in recent months. In fact, the semiconductor ETF SMH finished last week up 29% year-to-date, far outpacing the...
Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters (WAT) Boosts LC Solutions Portfolio With New Software
Waters (WAT) unveils HPLC CONNECT software, bolstering its liquid chromatography solutions portfolio.
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization
News Summary: Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved ease-of-use, efficiency, and data confidence in characterizing large molecules. HPLC CONNECT™ software accelerates precise characterization of complex molecules for the...
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
MILFORD, Mass. , Feb. 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Congresswoman Maxine Waters 'deeply opposed' to Capital One-Discover deal
Democrat Congresswoman Maxine Waters said on Wednesday she was "deeply opposed" to Capital One Financial's $35.3 billion planned acquisition of Discover Financial and called on banking regulators to block the deal.
Buy the Dip: 3 Oversold Stocks Poised for Big Gains
Traders can benefit from applying Relative Strength Index (RSI) signals in prevailing market conditions. One approach to consider which oversold stocks to buy is to wait for the RSI to cross back above 30% before considering an entry.
Source: https://incomestatements.info
Category: Stock Reports
How did Waters Corporation’s EPS change in 2023?
On a GAAP basis, EPS for fiscal year 2023 was $10.84, compared to $11.73 for fiscal year 2022. On a non-GAAP basis, EPS was $11.75, compared to $12.02 in fiscal year 2022. This includes a headwind of approximately 3% due to unfavorable foreign exchange and a 1% dilution from the Wyatt acquisition.
What were Waters Corporation’s revenue and profits in 2023?
For fiscal year 2023, the Company’s sales were $2,956 million, a decrease of 0.5% as reported, compared to sales of $2,972 million for fiscal year 2022. Currency translation decreased sales by approximately 1%, while the impact of acquisitions increased sales by 2.5%.
How did the Wyatt acquisition affect Waters’ 2023 financials?
In 2023, we completed the largest acquisition in Waters history with Wyatt Technology LLC, which contributed 2.5% to our revenues.